Genetic Collection Protocol

Description

This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.

Conditions

Liver Diseases

Talk to us

Study Overview

On this page

Study Details

Study overview

This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.

Genetic Collection Protocol

Genetic Collection Protocol

Condition
Liver Diseases
Intervention / Treatment

-

Contacts and Locations

Los Angeles

Children's Hospital of Los Angeles, Los Angeles, California, United States, 90027

San Francisco

UCSF Benioff Children's Hospital, San Francisco, California, United States, 94143

Aurora

Children's Hospital Colorado, Aurora, Colorado, United States, 80045

Atlanta

Children's Healthcare of Atlanta, Atlanta, Georgia, United States, 30322

Chicago

Lurie Children's Hospital, Chicago, Illinois, United States, 60611

Indianapolis

Riley Hospital for Children, Indianapolis, Indiana, United States, 46202

Cincinnati

Cincinnati Children's Hospital, Cincinnati, Ohio, United States, 45229

Philadelphia

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States, 19104

Pittsburgh

UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States, 15224

Houston

Texas Children's Hospital; Baylor College of Medicine, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * For Child Participants
  • 1. Previous enrollment in PROBE, BASIC, LOGIC, or MITOHEP
  • 2. Exited from one of the aforementioned studies.
  • 3. Consent for DNA sample collection obtained during enrollment during enrollment to one of the aforementioned studies but sample not previously collected.
  • 4. Still followed at the clinical site.
  • * For Biological Parent Participants
  • 1. Biological parents of previously consented child participant without collection of a parental DNA biospecimen.
  • 2. Child still followed at the clinical site.
  • * For Child Participants
  • 1. Participant is deceased
  • 2. Participant exited from prior study due to violating eligibility criteria
  • 3. Participant cannot be contacted
  • * For Biological Parent Participants
  • 1. Non-biological parent
  • 2. Child DNA was not previously collected and will not be collected in this study

Ages Eligible for Study

24 Hours to 25 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Arbor Research Collaborative for Health,

Ed Doo, MD, STUDY_DIRECTOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Averell Sherker, MD, STUDY_DIRECTOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

John Magee, MD, PRINCIPAL_INVESTIGATOR, University of Michigan

Lisa Henn, PhD, PRINCIPAL_INVESTIGATOR, Arbor Research Collaborative for Health

Study Record Dates

2029-05-31